Annie Yoshiyama insider trades: Allogene Therapeutics (ALLO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Annie reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | ALLO | ↓ Sell | 9,586 | $2.31 | $22K | Direct | Apr 23, 2026 (2d) |
| Feb 2, 2026 | ALLO | ↓ Sell | 4,167 | $1.72 | $7K | Direct | Feb 4, 2026 (2d) |
| Apr 21, 2025 | ALLO | ↓ Sell | 9,601 | $1.41 | $14K | Direct | Apr 23, 2025 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALLO insiders
Open-market trades in the last 12 months
About Annie Yoshiyama's insider trades
Annie Yoshiyama is SVP, Finance at Allogene Therapeutics (ALLO). Since Apr 21, 2025, Annie has reported no open-market purchases and 3 sales worth $43K on SEC Form 4. In the last 12 months: 2 sales ($29K).
Their filings also include grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.